Mattson Financial Services’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.98M Buy
38,275
+5,055
+15% +$337K 0.62% 51
2026
Q1
$2.09M Sell
33,220
-755
-2% -$52.6K 0.5% 66
2025
Q4
$2.25M Buy
33,975
+4,111
+14% +$266K 0.53% 64
2025
Q3
$2.01M Buy
29,864
+2,394
+9% +$189K 0.48% 73
2025
Q2
$2.4M Sell
27,470
-906
-3% -$71K 0.65% 58
2025
Q1
$1.94M Buy
28,376
+7,257
+34% +$592K 0.58% 66
2024
Q4
$1.42M Buy
21,119
+3,584
+20% +$265K 0.45% 79
2024
Q3
$1.99M Sell
17,535
-135
-0.8% -$11.1K 0.71% 51
2024
Q2
$2M Buy
+17,670
New +$2.23M 0.71% 51

Other funds holding DXCM

Mattson Financial Services's DXCM Position: Q2 2026 in Review

Mattson Financial Services increased its DexCom (DXCM) stake by 15% in Q2 2026, buying an estimated $337K and bringing the position to 38,275 shares worth $2.98M. The position accounts for 0.62% of the portfolio, ranked #51.

Mattson Financial Services first reported a position in DXCM in Q2 2024 and has held it in 9 quarters since. 968 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Mattson Financial Services held 38,275 shares of DexCom worth $2.98M as of Q2 2026.
  • Mattson Financial Services bought 5,055 DexCom shares in Q2 2026, an estimated $337K.
  • DexCom made up 0.62% of Mattson Financial Services's portfolio in Q2 2026, its #51 holding.
  • Mattson Financial Services first reported a position in DexCom in Q2 2024 and has held it in 9 quarters since.
  • 968 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Mattson Financial Services's 13F filing for Q2 2026, filed 4 Aug 2026.